MABFORGE Trademark
MABFORGE is a USPTO trademark filed by Alloy Therapeutics, Inc.. Status: Pending.
Trademark Facts
| Mark | MABFORGE |
|---|---|
| Serial Number | 98532731 |
| Status | Pending |
| Filing Date | 2024-05-03 |
| Mark Type | Word |
| Nice Classes | 001 (Chemicals), 042 (Software & IT), 045 (Legal Services) |
| Owner | Alloy Therapeutics, Inc. |
| Attorney of Record | Ian J. Block |
| Prosecution Events | 22 |
| Latest Event | EXRA on 2026-02-11 |
Goods & Services
Licensing of intellectual property to others in the fields of protein therapeutics, monoclonal antibodies, antibody-based constructs, multispecific antibodies, antibody fragments, single-domain antibodies, engineered antibody formats, and antibody derivatives; Protein molecules for scientific, laboratory and medical research use; Diagnostic reagents for scientific or research use; Chemicals for use in biotherapeutics and therapeutics product development and manufacturing processes, namely, chemicals for use in biotechnological product development; Biochemicals, namely, polypeptide encoding nucleic acids for laboratory research use; Monoclonal antibodies, antibody-based constructs, multispecific antibodies, antibody fragments, single-domain antibodies, engineered antibody formats, and antibody derivatives for scientific and medical laboratory research use; Research, development and consultation services in the fields of biotechnology, immunology, monoclonal antibodies, antibody-based constructs, multispecific antibodies, antibody fragments, single-domain antibodies, engineered antibody formats, antibody derivatives, vaccines, medicine, biotherapeutics, and therapeutics, namely, scientific research and development in the field of protein therapeutics, and conducting scientific research and development in the field of monoclonal antibodies, antibody-based constructs, multispecific antibodies, antibody fragments, single-domain antibodies, engineered antibody formats, and antibody derivatives for others; Genetic engineering services utilizing a collection of genetic technologies for the rapid production of human antibodies, human antibody fragments, and other proteins comprising such antibodies and fragments, namely, conducting genetic engineering for scientific research purposes for others, conducting testing, inspection, research, and development of protein therapeutic preparations for others; Scientific and medical research for use in antibody sequence humanization and optimization via deep mutational scanning (DMS); Conducting scientific medical and genetic research for others